Written by Technical Team | Last updated 27.02.2026 | 13 minute read
NHS organisations are under relentless pressure to modernise: reduce unwarranted variation, improve access, strengthen clinical safety, and unlock productivity, all while managing legacy estates, workforce constraints and ever-tighter capital and revenue envelopes. In that context, digital health consultancy can be a force multiplier—if it is procured well. Done badly, it becomes expensive “PowerPoint-as-a-service”, creates shelfware strategies, duplicates internal effort, and leaves you with vague deliverables that can’t survive operational reality.
For a CIO (or CCIO/CDIO equivalent), the challenge is not simply selecting a supplier. It is shaping the engagement so it accelerates measurable outcomes: safer pathways, faster flow, better data quality, improved resilience, more confident adoption, and sustainable capability transfer into your teams. The Health Systems Support Framework (HSSF) has been used as a compliant route to market for certain supportive services—often spanning digital and service transformation, analytics and population health, ICT and infrastructure support, and enabling work around shared care records and patient empowerment initiatives. The promise is speed and access to pre-qualified suppliers. The risk is treating HSSF as a shortcut rather than a structured buying method that still requires clarity, governance and strong commercial discipline.
This guide focuses on the decisions a CIO must make to procure digital health consultancy under HSSF in a way that is defensible, value-driven and delivery-focused. It is written for NHS trusts, foundation trusts, ICBs, CSUs and other NHS organisations navigating complex digital programmes where external consultancy is a strategic enabler rather than a substitute for leadership.
HSSF is best understood as a route to access supportive services from third-party suppliers without running a full standalone procurement every time you need specialist capability. In practice, that often means you can engage support for areas like digital transformation, clinical and operational change, advanced analytics, population health management, and the enabling foundations that make these things work in the real world: operating models, governance, service design, data quality improvement, interoperability planning, cyber readiness and programme delivery.
For a CIO, the most important mental shift is to view “digital health consultancy” as an outcomes instrument, not a body-count instrument. You are not buying “consultants”; you are buying an intervention that changes a system. The most effective engagements typically combine three elements: deep domain understanding of NHS operating constraints, technical credibility across modern digital architectures, and practical change capability that brings clinical and operational colleagues with you.
HSSF can also be attractive when you need to move at pace—responding to regulatory deadlines, urgent safety issues, cyber remediation, EPR optimisation, shared care record connectivity or major service reconfiguration. But pace is only helpful when you have defined what “good” looks like. Without crisp outcomes, you can procure quickly and still lose months circling around unclear scope, contested ownership, and deliverables that do not translate into adoption.
It is also worth being realistic about what a framework can and cannot do for you. A framework can reduce procurement friction, but it does not remove the need for: a clear statement of need, a sensible evaluation model, proportionate due diligence, strong information governance, and contract management. If anything, frameworks can increase the risk of complacency—because the buying mechanism feels “pre-approved”. In today’s environment of heightened scrutiny around value, transparency and supplier performance, you should assume that your rationale and audit trail may be examined later, regardless of route to market.
Finally, note that governance and support arrangements around frameworks can evolve. Even when a framework route exists, NHS organisations may need to be more self-sufficient in initiating and managing call-offs, leaning on internal procurement teams, local procurement hubs, CSUs or specialist commercial support rather than expecting central facilitation. The practical implication for a CIO is simple: build a repeatable internal playbook so your organisation can procure digital consultancy consistently, quickly and safely.
The single biggest determinant of success is the quality of your brief. A weak brief produces a weak outcome, no matter how good the supplier. A strong brief does three things: it defines the problem in operational terms, it articulates measurable outcomes and constraints, and it sets boundaries that prevent scope drift while leaving room for expert challenge.
Start by expressing the problem as a service performance gap, safety risk or strategic capability deficit—not as a shopping list of activities. “We need a digital strategy” is vague; “we need an executable roadmap to reduce outpatient follow-up demand by enabling remote monitoring in two pathways, while improving patient-initiated follow-up adoption and ensuring clinical safety governance is in place” is specific and forces the consultancy towards operational value.
Then translate that into outcomes with evidence. Outcomes should be a blend of patient, workforce and system measures, with a pragmatic time horizon. Some benefits will land quickly (reduced manual work, improved data quality, faster reporting cycles), while others are longer-cycle (pathway redesign, behavioural change, stabilised supplier ecosystem). A credible business case distinguishes between cash-releasing savings, cost avoidance, productivity and quality improvements, and it states clearly which are realistic in your context.
Scope boundaries are the second pillar. Digital health consultancy can sprawl across strategy, architecture, procurement support, clinical safety, data, operational change and training. You need to decide what is in and out. For example, are you asking for a target operating model for a virtual ward expansion, or are you also asking for market engagement and procurement artefacts? Are you asking for an interoperability blueprint, or also for hands-on integration build support? If you don’t set boundaries, suppliers will interpret them for you—often in ways that optimise utilisation rather than outcomes.
The third pillar is internal readiness. Before you go to market, be honest about the constraints that will shape delivery: decision-making speed, clinical leadership bandwidth, data quality, supplier lock-in, integration constraints, and the maturity of your portfolio governance. A consultancy cannot “fix” slow governance or lack of executive sponsorship. But you can design the engagement to compensate—for example, by explicitly including facilitated decision forums, rapid discovery sprints, or capability transfer into a PMO.
Finally, design deliverables that are usable. Insist on artefacts that become living tools: a prioritised backlog rather than a static roadmap; an architecture decision record set rather than a glossy diagram; an implementation plan tied to your portfolio cadence; and training assets that your teams can reuse. The more your brief demands operationally embedded outputs, the less likely you are to end up with shelfware.
Under a framework route, the core strategic choice is typically whether you can justify a direct award or whether you should run a further competition (often called a mini-competition). The right answer depends on your risk appetite, the complexity of the requirement, how differentiated you expect supplier approaches to be, and how important it is to test the market on price and methodology.
A direct award can be appropriate when the requirement is well-bounded, time-critical, and you can defend why a particular supplier is the best fit based on objective reasons—such as unique capability, proven delivery in comparable NHS contexts, or continuity with an existing programme where switching costs would create disproportionate risk. The danger is that “speed” becomes the only justification. If your internal stakeholders are divided, your requirements are ambiguous, or you anticipate significantly different delivery approaches, a further competition can actually save time later by forcing clarity early.
A further competition is often more appropriate for complex transformation work where methodology and cultural fit matter as much as credentials. It helps you compare approaches to discovery, stakeholder engagement, clinical safety governance, data handling, and capability transfer. It also provides a more robust audit trail for value for money. The trade-off is procurement effort—but that effort can be tightly managed with a disciplined timetable and a crisp pack.
Whichever route you choose, your procurement strategy should be designed to protect delivery outcomes. That means avoiding evaluation models that overweight generic experience and underweight how the supplier will work in your environment. It also means ensuring you can actually mobilise quickly once the award is made: internal approvals, onboarding, access to systems, information governance sign-off, and clinical engagement must be planned upfront.
Key decisions to lock down early include:
A practical tip for CIOs is to separate speed from urgency. If the situation is genuinely urgent (for example, a safety issue, a cyber remediation deadline, or an external regulatory requirement), compress the process but do not weaken the brief. Time pressure is exactly when vague scopes become most expensive. A short, well-structured discovery phase can be built into the contract so you mobilise fast while still validating assumptions before committing to major downstream work.
Digital health consultancy in the NHS sits at the intersection of technology, clinical risk, information governance, and operational change. Your evaluation therefore needs to test more than reputation and CVs. It must test whether the supplier can deliver safely, compliantly and practically within NHS constraints.
Start with delivery confidence. Ask for a clear mobilisation plan, named roles, and the mechanisms they will use to run work: governance cadence, decision-making approach, backlog management, stakeholder engagement, and escalation routes. The best suppliers show you how they will reduce risk, not just how they will produce outputs. They also demonstrate how they will work with CCIOs, nursing leadership, operations and finance—not only the digital function.
Interoperability and architecture should be assessed in a way that is relevant to your current state. Many consultancies can speak fluently about “modern architectures”; fewer can navigate the reality of legacy PAS/EPR constraints, integration engine limitations, supplier contract boundaries, and the data quality issues that distort analytics. Evaluate how the supplier makes trade-offs, documents architecture decisions, and protects future optionality. If you are pursuing shared records connectivity, population health analytics, or cross-organisational workflows, you need consultancies that can operate across organisational boundaries and understand multi-party governance.
Information governance and cyber readiness are non-negotiable. If the consultancy will handle personal data, access clinical systems, or shape data flows, you must test their approach to data protection, security controls, and incident management. Even if they only advise, their artefacts may set patterns that affect future compliance. A credible supplier can explain, in plain terms, how they minimise data access, how they segregate environments, and how they support your organisation’s risk owners.
When you compare suppliers, keep the assessment grounded in evidence. Useful evidence is not limited to case studies; it includes templates they have used, examples of artefacts (appropriately redacted), and short “show-and-tell” sessions where they walk you through how they run a discovery sprint or produce a clinical safety case. If you can’t see their working, you can’t evaluate it.
A robust evaluation typically tests the following areas explicitly:
Finally, treat “culture” as a procurement criterion, not a vibe. In the NHS, the consultancy’s ability to build trust across clinical and operational stakeholders is often the deciding factor in whether change lands. Ask how they handle challenge, how they work with scepticism, how they co-design with frontline teams, and how they communicate risk. A supplier that over-promises early is likely to under-deliver later; you are looking for calm confidence backed by structured delivery discipline.
Once the contract is signed, the real work begins. Many organisations assume the procurement decision ends at award; in reality, award is merely permission to start. The value is created—or destroyed—through mobilisation, governance and benefits realisation.
Mobilisation should be treated as a formal phase with clear entry and exit criteria. Ensure the supplier understands your operating model and that your organisation is ready to receive them: access requests, system onboarding, IG approvals, clinical sponsor availability and workspace arrangements. A two-week mobilisation that drifts into six weeks will erode confidence quickly and create pressure to cut corners later.
Governance must be proportionate but firm. For digital health consultancy, a layered governance model works well: an operational working group for day-to-day delivery decisions, a fortnightly or monthly programme board for scope, risk and dependency management, and executive oversight where necessary for decisions that cut across functions. Make sure the consultancy cannot “outpace” your decision-making: build decision points into the plan, timebox debates, and document decisions to prevent circular discussions.
Commercially, protect your organisation with clarity and control. Where you use time-and-materials, agree a capped budget and define what triggers a formal change control. Where you use fixed price, define acceptance criteria and require tangible outputs that you can reuse. In both cases, insist on transparency: weekly burn, progress against outcomes, and a visible backlog of work.
Benefits realisation is where many consultancy engagements fail silently. A consultancy may deliver exactly what the contract asked for and still not produce value. The CIO’s role is to connect consultancy outputs to operational adoption: training, workflow changes, SOP updates, clinical governance sign-off, and handover into BAU. Require a benefits plan that names owners, baselines measures, and shows when benefits are expected to accrue. If benefits rely on internal change activity, surface that explicitly and secure commitment early.
A strong exit plan should be in place from the start. Consultancy value is maximised when your teams can continue without them. That means structured knowledge transfer, handover of artefacts in usable formats, documentation of decisions and assumptions, and, where appropriate, mentoring of internal staff. If the engagement has produced technical designs, make sure ownership is unambiguous and that you have the rights and access you need to implement and maintain them.
Finally, do not underestimate the reputational dimension. Digital programmes are visible, politically sensitive and often emotionally charged for frontline staff. A consultancy that behaves like an external “answer” can damage internal credibility. The best engagements position the NHS organisation as the owner and leader, with consultancy as an accelerator. When that balance is right, consultancy spend translates into lasting capability, stronger governance, and delivery momentum that survives beyond a single contract cycle.
Is your team looking for help with digital health consultancy? Click the button below.
Get in touch